Ventricular Tachycardia

Ventricular tachycardia (VT) is a serious cardiac arrhythmia characterized by rapid electrical signals originating in the ventricles, the lower chambers of the heart. Unlike normal rhythm, VT causes the heart to beat excessively fast, often exceeding 100 beats per minute. This disrupts effective blood circulation, leading to dizziness, palpitations, chest pain, or even loss of consciousness. Sustained VT can progress to ventricular fibrillation, a fatal rhythm if not treated promptly.

The condition is commonly associated with underlying heart disease, such as coronary artery disease, prior heart attacks, cardiomyopathy, or structural abnormalities. Electrolyte imbalances, certain medications, and genetic disorders can also trigger VT episodes. Diagnosis typically involves electrocardiograms (ECG), Holter monitoring, and imaging studies to identify structural causes.

Treatment strategies depend on severity and recurrence. Acute episodes may require antiarrhythmic drugs or electrical cardioversion to restore normal rhythm. Long-term management can include implantable cardioverter-defibrillators (ICDs), catheter ablation, and lifestyle modifications to reduce risk factors. Preventive care, such as managing hypertension, diabetes, and avoiding stimulants, plays a crucial role.

Ventricular tachycardia is a medical emergency when symptomatic, and timely intervention is vital to prevent sudden cardiac death. Awareness and early detection significantly improve outcomes.